Yanmeng Li

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 5

Top Topics

Advanced Non Small Cell Lung Cancer

Signaling Pathway

Top Venues

American journal of hematology

Hepatology international

Liver international : official journal of the International Association for the Study of the Liver

Thoracic cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Yanmeng Li, Anjian Xu, Susu Liu, Wei Zhang, Donghu Zhou, Qin OuYang, Huaduan Zi, Bei Zhang, Ning Zhang, Wei Geng, Yiming Zhou, Weijia Duan, Xiaoming Wang, Xinyan Zhao, Xiaojuan Ou, Changfa Fan, Jidong Jia, Jian Huang
SUGP2 p.(Arg639Gln) variant is involved in the pathogenesis of hemochromatosis via the CIRBP/BMPER signaling pathway. American journal of hematology (2024)
Yanmeng Li, Anjian Xu, Susu Liu, Wei Zhang, Donghu Zhou, Qin OuYang, Huaduan Zi, Bei Zhang, Ning Zhang, Wei Geng, Yiming Zhou, Weijia Duan, Xiaoming Wang, Xinyan Zhao, Xiaojuan Ou, Changfa Fan, Jidong Jia, Jian Huang
SUGP2 p.(Arg639Gln) variant is involved in the pathogenesis of hemochromatosis via the CIRBP/BMPER signaling pathway. American journal of hematology 99 (9) (2024)
Shirong Li, Saiping Qi, Yanmeng Li, Chunpan Zhang, Lan Sun, Chun-Quan Liu, Hao-Yan Wang
MARVELD3 inhibits the epithelial-mesenchymal transition and cell migration by suppressing the Wnt/β-catenin signaling pathway in non-small cell lung cancer cells. Thoracic cancer (2023)
Yanmeng Li, Anjian Xu, Qin Ouyang, Wei Zhang, Chunpan Zhang, Zhibin Chen, Donghu Zhou, Bei Zhang, Weijia Duan, Xinyan Zhao, Xiaoming Wang, Hong You, Xiaojuan Ou, Jidong Jia, Jian Huang
DENND3 p.L708V activating variant is involved in the pathogenesis of hereditary hemochromatosis via the RAB12/TFR2 signaling pathway. Hepatology international (2023)
Wei Zhang, Anjian Xu, Yanmeng Li, Su-Xian Zhao, Donghu Zhou, Lina Wu, Bei Zhang, Xin-Yan Zhao, Yu Wang, Xiaoming Wang, Weijia Duan, Qianyi Wang, Yuemin Nan, Hong You, Jidong Jia, Xiaojuan Ou, Jian Huang, null null
A novel SLC40A1 p.Y333H mutation with gain of function of ferroportin: A recurrent cause of haemochromatosis in China. Liver international : official journal of the International Association for the Study of the Liver 39 (6) (2018)